TG101209 50mg 50mg | Purity Not Available
Adooq Bioscience
TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells.
More Information Supplier PageSearch Results
TG101209 5mg 5mg | Purity Not Available
Adooq Bioscience
TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells.
More Information Supplier PageTG101209 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells.
More Information Supplier PageTG101209 100mg 100mg | Purity Not Available
Adooq Bioscience
TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells.
More Information Supplier PageTG101209 10mg 10mg | Purity Not Available
Adooq Bioscience
TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells.
More Information Supplier PageNSC-207895 50mg 50mg | Purity Not Available
Adooq Bioscience
NSC207895 is a cell-permeable benzofuroxan compound that downregulates the p53 negative regulator MDMX protein level in MCF-7, LNCaP, and A549 cells (1 to 10 µM for 16 to 24 h) by suppressesing MDMX promoter transcription activity (IC50 = 2.5 µM in HT1080 cells), leading to enhanced p53 stabilization and activation.
More Information Supplier PageADX-47273 5mg 5mg | Purity Not Available
Adooq Bioscience
ADX-47273 is a drug used in scientific research which acts as a positive allosteric modulator selective for the metabotropic glutamate receptor subtype mGluR5.
More Information Supplier PageADX-47273 50mg 50mg | Purity Not Available
Adooq Bioscience
ADX-47273 is a drug used in scientific research which acts as a positive allosteric modulator selective for the metabotropic glutamate receptor subtype mGluR5.
More Information Supplier PageClinofibrate 100mg 100mg | Purity Not Available
Adooq Bioscience
Clinofibrate is a lipid clearing agent that appears to modify lipid metabolism, diminishing the steroid induced accumulation of lipids within osteocytes. It also can effectively reduce the plasma fibrinogen level.
More Information Supplier PageClinofibrate 10mg 10mg | Purity Not Available
Adooq Bioscience
Clinofibrate is a lipid clearing agent that appears to modify lipid metabolism, diminishing the steroid induced accumulation of lipids within osteocytes. It also can effectively reduce the plasma fibrinogen level.
More Information Supplier Page